Nayan Shree, a 29-year-old software engineer from Belagavi, had scleroderma for many years, which caused the reduced blood supply to her great toe. However, despite taking medications and visiting several doctors, she could not find relief from the pain. Scleroderma is a rare autoimmune disorder affecting the skin and internal organs. It causes the hardening and tightening of the skin, as well as the blood vessels, which can lead to the reduced blood supply to different parts of the body.
Scleroderma is a rare and challenging autoimmune disorder that can cause various symptoms. The condition can affect the skin, blood vessels, and internal organs, reducing blood flow and pain in different body parts. The situation can also be challenging to diagnose and treat, which can cause frustration and anxiety for patients.
The symptoms of scleroderma can vary depending on the type and severity of the condition. However, the most common symptoms include hardening and tightening of the skin, joint pain and stiffness, and reduced blood supply to different body parts. For example, Nayan Shree experienced severe pain in her toe due to reduced blood supply, affecting her ability to walk and carry out her daily activities.
Nayan Shree visited Kerur Pain Clinic and consulted with Dr. Ravi about her condition. Dr. Ravi recommended a combination of neuromodulation and injection therapy to help manage her pain and improve her blood supply to her great toe. Neuromodulation therapy involves using a small device that delivers electrical pulses to the nerves in the affected area, helping reduce pain and improve blood flow. Injection therapy injects medication directly into the affected area to provide targeted relief.
After undergoing neuromodulation therapy and injection therapy for four weeks, Nayan Shree experienced a significant improvement in her condition. The pain in Nayan Shree's great toe was reduced, and she could walk and carry out her daily activities quickly. The treatment also helped improve the blood supply to her toe, reducing pain and discomfort.
In conclusion, scleroderma is a rare and challenging autoimmune disorder that can cause various symptoms. However, with the correct diagnosis and treatment, it is possible to manage the symptoms and improve the quality of life for patients. Nayan Shree's case is a prime example of how a combination of neuromodulation therapy and injection therapy can help manage pain and improve the blood supply in patients with scleroderma.